Doxorubicin alone versus doxorubicin with trabectedin followed by trabectedin alone as first-line therapy for metastatic or unresectable leiomyosarcoma (LMS-04): a randomised, multicentre, open-label phase 3 trial
Titel:
Doxorubicin alone versus doxorubicin with trabectedin followed by trabectedin alone as first-line therapy for metastatic or unresectable leiomyosarcoma (LMS-04): a randomised, multicentre, open-label phase 3 trial
Auteur:
Pautier, Patricia Italiano, Antoine Piperno-Neumann, Sophie Chevreau, Christine Penel, Nicolas Firmin, Nelly Boudou-Rouquette, Pascaline Bertucci, François Balleyguier, Corinne Lebrun-Ly, Valérie Ray-Coquard, Isabelle Kalbacher, Elsa Bardet, Aurélie Bompas, Emmanuelle Collard, Olivier Isambert, Nicolas Guillemet, Cécile Rios, Maria Archambaud, Baptiste Duffaud, Florence